Kirsty McCormack

University of Aberdeen

Papers

1

Total Citations

14

H-Index

1

About

Kirsty McCormack is a leading clinical researcher in perioperative medicine, with a particular focus on enhancing recovery after colorectal surgery. Her work centers on optimizing gastrointestinal function and reducing postoperative complications through evidence-based interventions. She is best known for her pivotal role in the landmark ALLEGRO trial (2022), a placebo-controlled randomized study investigating intravenous lidocaine to accelerate gastrointestinal recovery after colorectal surgery. This high-impact trial addressed a critical clinical challenge—delayed return of GI function, which affects up to 40% of patients—and has shaped current perioperative care protocols. With over 14 citations and growing influence, the ALLEGRO trial exemplifies her commitment to rigorous, patient-centered research. McCormack’s contributions have advanced understanding of multimodal analgesia and recovery pathways, directly improving surgical outcomes. Her work is widely cited by anesthesiologists and colorectal surgeons, reflecting its practical significance. Through her research, McCormack continues to drive innovation in perioperative medicine, making her a respected voice in the field and a valuable resource for students and clinicians seeking to improve surgical recovery.

Research Focus

Key Achievements

1
H-Index
1
Papers
14
Total Citations
14
Avg Citations/Paper
🏆 Most Cited Paper
The ALLEGRO trial: a placebo controlled randomised trial of intravenous lidocaine in accelerating gastrointestinal recovery after colorectal surgery
14 citations · 2022
📈 Most Prolific Year: 2022 (1 Papers)
🤝 Key Collaborators: 12
🏛 Institutions: University of Aberdeen

Top Papers

  1. 1

Key Collaborators

Contact & Links

Available for collaboration
Content generated · 13 days ago